Journal article
A phase II trial of perifosine as second line therapy for advanced pancreatic cancer. A study of the Princess Margaret Hospital [PMH] Phase II Consortium
Authors
Hedley D; Moore MJ; Hirte H; Siu L; Vincent M; Jonker D; Mwang H; Nagai J; Dancey J
Journal
Journal of Clinical Oncology, Vol. 23, No. 16_suppl, pp. 4166–4166
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
June 1, 2005
DOI
10.1200/jco.2005.23.16_suppl.4166
ISSN
0732-183X